Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials
IntroductionPatients with type 2 diabetes (T2D) are at increased risk of respiratory diseases, but the effects of novel glucose-lowering drugs on respiratory diseases remain unclear.MethodWe conducted a systematic review and meta-analysis of 27 large randomized controlled trials (202,727 participant...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-01-01
|
| Серія: | Frontiers in Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1721311/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|